Lorenzo Fiorani joins Amplifon Spain as General Manager

Lorenzo Fiorani Gaes Amplifon

The Widex and Sivantos merger is on again

Sivantos and Widex

"The digital transformation will not replace experts"

François Julita

Get the latest news of the profession: sign up for our newsletter!

Audiology Worldnews newsletter

Interested in Audiology-related events?

Audiology Worldnews agenda

TINNET as the next step in tinnitus research: Towards evidence-based medicine

The Tinnitus Research Initiative (TRI) has come a long way to bring tinnitus research from several scientific fields together. The European funded TINNET, 'Better Understanding the Heterogeneity of Tinnitus to Improve and Develop New Treatments', can be regarded as the next step. It aims at coordination and standardization in tinnitus research and the enlargement of an already existing database with results from clinical trials. This should lead to a statistically relevant basis for tinnitus research. It promises the opportunity of standardized processes to enable tailor-made assessment for individual patients.

“At the start of the TRI in 2006 as a private initiative, there was only little tinnitus research compared to the number of people suffering from it. This research was isolated and results remained within the separated domains of ENT, audiology, psychology, psychiatry, and etcetera”, Dr. Berthold Langguth, head of the tinnitus center of Regensburg University concludes. TRI had the vision to bring disciplines together and to share results and insights. “Back then”, Langguth remembers, “the general assumption and conclusion were: 'Tinnitus cannot be cured, so learn to live with it'. The people involved in TRI, however, shared the belief that tinnitus should be treatable in principle – for instance with brain stimulation– although this treatment nor any other treatment was not proven yet. Their motto was and still is: 'Together for a cure'.” Since then, a lot has been achieved. For many patients, the suffering from tinnitus has been reduced.

Evidence base

“But tinnitus still is a very heterogeneous illness. It is difficult to treat”, says Langguth, “treatment is for a large part still mainly pioneering, the domain of pilot studies.” As yet, there are no clearly evidence based treatment methods except cognitive behavioral therapy (CBT) – which comes in several forms. Langguth: “But this doesn't affect the tinnitus percept itself, CBT has the goal to facilitate coping with it. While this provides important relief in many cases, it is not yet the solution for every patient suffering from tinnitus. Apart from that, there are many, many approaches with different rationales. Hearing loss compensation, optionally combined with forms of auditory stimulation, is widely accepted, but large controlled studies demonstrating the efficacy of these approaches are needed. Various innovative forms of individualized auditory stimulation offer sounds or music in frequency areas in the neighborhood of the tinnitus frequency. These forms of individualized auditory stimulation can interact with the neuronal mechanisms that generate tinnitus and have shown promising results in pilot studies.” But there is still a lot unclear, Langguth emphasizes: “How large are the clinical effects? Which variant works best with which type(s) of patients? What can we expect from pharmacological treatment or magnetic and electric brain stimulation? Before these newly developed treatments can be implemented in clinical routine, a conclusive statistical basis from large studies would be needed.”

New knowledge

The TINNET initiative was initiated to change this. It has now been approved by the European Cooperation in Science and Technology (COST) Committee of Senior Officials, thus ensuring European funding. “With that, we get the opportunity to lift tinnitus research to the next level. We still largely depend on the outcomes of isolated trials with a couple of dozens of heterogeneous patients, which causes results to partly depend on group configuration. When data from similar trials from dozens of centers or more can henceforth be introduced in the database, this opens a lot of opportunities.” Once detailed data from many persons is gathered, it will allow us to derive new knowledge, says Langguth: “We could understand in more detail what forms of tinnitus do exist and what the differences between the various forms are. The goal would be to create a data-based expert system, which would provide guidance of which treatment has the best chances for success in a given patient: So hopefully in some years, we can ask the database what would be the recommendation for a 56 years old male, who suffers from a tonal tinnitus since a noise trauma two years ago, and the database would tell us, that a combination of drug X and auditory stimulation Y is the most promising first-line treatment for this individual.”

Dr. Berthold Langguth held a speech on the TINNET initiative during the 8th TRI international Conference from 10-13 March in Auckland, New Zealand. COST invites tinnitus researchers from as many European countries as possible to participate in the project.

Leendert van der Ent


Photo: Lasse Designen - Fotolia
Amplifon signs deal to help low-income hearing disabled in Spanish region of Asturias
Amplifon signs deal to help low-income hearing disabled in Spanish region of Asturias

solidarity

©hudiemm/iStock

The hearing giant, Amplifon, has teamed up with a non-profit organisation in Asturias, Spain for a one-year deal to provide access to hearing aids and treatment for the region's poor hearing-disabled.

Implantation overtakes hearing aid fitting in pediatric populations in Spain
Implantation overtakes hearing aid fitting in pediatric populations in Spain

TRENDS

© DuxX-iStock

For the first time, the sale of implants has overtaken that of hearing aids as the most-used technology for children in the treatment of hearing loss, as evidenced by the comparative data of two studies carried out in 2005 and 2018 by FIAPAS, (the Spanish confederation of families of deaf people).

Newly discovered Usher syndrome mutations may help confirm diagnoses of rare condition
Newly discovered Usher syndrome mutations may help confirm diagnoses of rare condition

deafblindness

© Konoplytska/iStock

A Moscow-based study has discovered several new mutations behind the rare Usher syndrome variety of deafblindness. Researchers say the finding can be useful in confirming diagnosis of the condition.

Eric Timm appointed CEO of Sivantos, Inc.
Eric Timm appointed CEO of Sivantos, Inc.

Nomination

©Sivantos

Sivantos, Inc. announced on February 1 the appointment of Eric Timm to the role of chief executive officer.

3M to pay $9.1m to settle claims it sold defective earplugs
3M to pay $9.1m to settle claims it sold defective earplugs

Litigation

©PeopleImages/iStock

The US multinational 3M has agreed to a $9.1m payment to end a dispute over allegations it knowingly sold defective combat ear plugs to the U.S. military.

Study highlights hearing aid limitations for orchestra musicians with hearing loss
Study highlights hearing aid limitations for orchestra musicians with hearing loss

music

©Furtseff/iStock

What do musicians with hearing loss most fear? A new study suggests their hearing aids have limitations when it comes to following the finer details of music and instructions from conductors.

Wireless earwear reaches fashion zenith - Louis Vuitton AirPods earphones anyone?
Wireless earwear reaches fashion zenith - Louis Vuitton AirPods earphones anyone?

style

©eyewave/iStock

A challenge to the status effect of the Apple AirPod—which has been trumpeted as a makeshift hearing aid—is being launched by the Paris fashion house Louis Vuitton in the form of designer wireless earphones.

Company Directory

New products

GSI releases new tests on the TympStar ProGSI releases new tests on the TympStar Pro

GSI has released new tests that are available on the company’s clinical tympanometer, the TympStar Pro.  [ ... ]

Ida Institute's My World tool now available as an appIda Institute's My World tool now available as an app

My World is a free pediatric counseling tool from the Ida Institute designed to help children talk about their hearing loss.  [ ... ]

Dreve highlights at EUHA 2018

At the EUHA 2018, Dreve launched the first and unique 3D direct to print silicone BioTec, which is revolutionizing the digital earmold production.  [ ... ]